Management of Non-Epithelial Ovarian Tumours

Abstract

Ovarian tumours of non-epithelial origin are less common than those of epithelial origin but must be distinguished from these as their natural history and management differ. As these tumours are rare, histological review by an expert in the field is essential. There have been no randomised trials to outline the management of these tumours and therefore this paper represents a review of descriptive data. Non-epithelial ovarian tumours, which represent approximately 50% of all ovarian tumours and approximately 25% of malignant ovarian tumours, are outlined. Lymphomas and metastatic tumours should be treated the same as when found in other sites and will not be discussed further.

Feasibility and efficacy of laparoscopic management of ovarian cancer

“…In three patients with granulose cell tumors, we detected enlarged lymph nodes surpassing stage IA, so we performed radical surgery including lymphadenectomy for these patients. 12 In one case with a carcinoid tumor, frozen-section examination identified the mass as a sex cord stromal tumor containing a mature cystic teratoma. Based on this finding, accurate surgical staging was performed.…”

“…For patients with borderline ovarian tumors, we performed complete surgical staging necessary for invasive ovarian cancers because the frozen biopsies had indicated more critical results compared to the borderline tumors. In three patients with granulose cell tumors, we detected enlarged lymph nodes surpassing stage IA, so weperformed radical surgery including lymphadenectomy for these patients 12 . In one case with a carcinoid tumor, frozen‐section examination identified the mass as a sex cord stromal tumor containing a mature cystic teratoma.…”

Dysgerminoma in a Patient with a Tumor of the Neck

“…Therefore it is important to select the method of treatment. Because of the toxicity to ovarian function and the local effect of treatment, radiotherapy for young patients or those with advanced dysgerminoma has been replaced by chemotherapy [8]. For these reasons we concluded that combination chemotherapy is most effective in an advanced case like ours, in which the patient complains of respiratory distress, chest pain and other symptoms.…”

Hormonaktive Ovarialtumoren

“…Auch Korpuskarzinome werden gehäuft beobachtet und mit einer Inzidenz bis zu 22% beschrieben [9]. Auch die Inzidenz von Mammakarzinomen scheint bei Patientinnen mit dieser Erkrankung gehäuft zu sein [3].…”